Previous studies have demonstrated that XIAP expression is up-regulated in lung cancer, prostate cancer, OSA and other tumors, while its high expression level has relation with unfavorable prognosis of patients [21–23], yet the upstream molecular mechanism leading to XIAP abnormal expression in OSA remains to be elucidated. Here, XIAP is linked to prostate carcinoma.